CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | Burke William Patrick Chief Human Resources Officer | Grant or award · Options to Buy Ordinary Shares | +13,038 | $80.59 | $1.1M | 13,038 |
| 2022-03-03 | Burke William Patrick Chief Human Resources Officer | Grant or award · Options to Buy Ordinary Shares | +4,361 | $80.59 | $351K | 4,361 |
| 2022-03-03 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +21,921 | 171,895 | ||
| 2022-03-03 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −1,301 | $74.50 | $97K | 170,594 |
| 2022-03-03 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award · Options to Buy Ordinary Shares | +38,390 | $80.59 | $3.1M | 38,390 |
| 2022-03-03 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award · Options to Buy Ordinary Shares | +7,664 | $80.59 | $618K | 7,664 |
| 2022-03-03 | Leonard Frank X Chief Development Officer | Grant or award | +17,371 | 104,524 | ||
| 2022-03-03 | Leonard Frank X Chief Development Officer | Sale | −930 | $74.50 | $69K | 103,594 |
| 2022-03-03 | Leonard Frank X Chief Development Officer | Grant or award · Options to Buy Ordinary Shares | +30,422 | $80.59 | $2.5M | 30,422 |
| 2022-03-03 | Leonard Frank X Chief Development Officer | Grant or award · Options to Buy Ordinary Shares | +4,933 | $80.59 | $398K | 4,933 |
| 2022-01-06 | Weinberg Uri Chief Science Officer | Grant or award | +35 | $63.82 | $2K | 31,815 |
| 2022-01-06 | Burke William Patrick Chief Human Resources Officer | Grant or award | +80 | $63.82 | $5K | 50,950 |
| 2022-01-06 | Benaim Ely Chief Medical Officer | Grant or award | +55 | $63.82 | $4K | 28,199 |
| 2022-01-06 | Cordova Ashley Chief Financial Officer | Grant or award | +46 | $63.82 | $3K | 41,804 |
| 2022-01-06 | Danziger Asaf Chief Executive Officer | Grant or award | +31 | $63.82 | $2K | 13,307 |
| 2022-01-06 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +75 | $63.82 | $5K | 149,974 |
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Exercise or conversion | +17,452 | $11.46 | $200K | 43,669 |
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Sale | −2,633 | $75.96 | $200K | 41,036 |
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Exercise or conversion | +9,750 | $7.15 | $70K | 50,786 |
| 2022-01-03 | Burke William Patrick Chief Human Resources Officer | Sale | −919 | $76.09 | $70K | 49,867 |
Page 24 of 32 · 638 trades